Key Metrics
CiteScore 

5.4
Impact Factor 

< 5
SJR 

Q2Medicine (miscellaneous)

SNIP 

1.43
Recommended pre-submission checks
Powered by 

Topics Covered on Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 12 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Chronic Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Therapeutic Advances in Chronic Disease
Frailty and its association with mental health and quality of life in multiple sclerosis: A cross-sectional study
- 1 Jan 2026
- Therapeutic Advances in Chronic Disease
Factors associated with disease knowledge and medication adherence among rheumatoid arthritis patients attending a private rheumatology clinic: A cross-sectional study
- 1 Jan 2026
- Therapeutic Advances in Chronic Disease
The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: a review
- 1 Nov 2025
- Therapeutic Advances in Chronic Disease
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
- 1 Nov 2025
- Therapeutic Advances in Chronic Disease
Staging and markers in Parkinson’s disease and Lewy body disorders: narrative review
- 1 Oct 2025
- Therapeutic Advances in Chronic Disease
The evidence for ketamine treatment in older adults with psychiatric illness: a scoping review
- 1 Oct 2025
- Therapeutic Advances in Chronic Disease
Frailty and its association with mental health and quality of life in multiple sclerosis: A cross-sectional study
- 1 Jan 2026
- Therapeutic Advances in Chronic Disease
Factors associated with disease knowledge and medication adherence among rheumatoid arthritis patients attending a private rheumatology clinic: A cross-sectional study
- 1 Jan 2026
- Therapeutic Advances in Chronic Disease
The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: a review
- 1 Nov 2025
- Therapeutic Advances in Chronic Disease
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
- 1 Nov 2025
- Therapeutic Advances in Chronic Disease
Staging and markers in Parkinson’s disease and Lewy body disorders: narrative review
- 1 Oct 2025
- Therapeutic Advances in Chronic Disease
The evidence for ketamine treatment in older adults with psychiatric illness: a scoping review
- 1 Oct 2025
- Therapeutic Advances in Chronic Disease